Novel Armed Pyrazolobenzothiazine Derivatives: Synthesis, X-Ray Crystal Structure and POM analyses of Biological Activity Against Drug Resistant Clinical Isolate of Staphylococcus aureus
- 128 Downloads
- 1 Citations
Novel structural hybrids of pyrazolobenzothiazine and triazole ring systems have been prepared to observe a synergistic effect of the two ring systems. The methodology involves condensation of pyrazolobenzothiazine rings with methyl chloroacetate, followed by hydrazide formation. The hydrazides were converted to triazoles through the formation of intermediate potassium salts of dithiocarbazate. The final compounds as well as intermediates were screened for their antibacterial activity against a multidrug resistant strain of Staphylococcus aureus. It was interesting to observe that dithiocarbazates (7a, 7b) and target triazoles (8a, 8b) exhibited antibacterial activity.
Keywords
pyrazolobenzothiazine dioxides triazole antibacterial pharmacophore site Petra/Osiris/Molinspiration (POM) analysesNotes
Acknowledgements
One of the authors (M. Ahmad) highly acknowledges “Higher Education Commission of Pakistan” for providing “Startup research grant” No. PM-IPFP/HRD/HEC/2011/382. Professor T. Ben Hadda would like to thank ACTELION, the Biopharmaceutical Company of Swiss, for the calculations of molecular properties.
References
- 1.N. S. Jayasundara, MSc Thesis, Queensland University of Technology, Brisbane, Australia (2014).Google Scholar
- 2.L. G. Miller and B. A. Diep, Clin. Infect. Dis., 46, 752 – 760 (2008).CrossRefPubMedGoogle Scholar
- 3.A. Mastoraki, I. Kriaras, E. Douka, et al., Interact. Cardiovasc. Thor. Surg., 7, 452 – 456 (2008).CrossRefGoogle Scholar
- 4.M. E. Stryjewski and G. R. Corey, Clin. Infect. Dis., 58, S9 – S10 (2014).CrossRefGoogle Scholar
- 5.F. Şahin, I. Karaman, M. Güllüce, H. Öðütçü, et al., J. Ethnopharmacol., 87, 61 – 65 (2003).CrossRefPubMedGoogle Scholar
- 6.G. Ravizzola, G. Pinsi, M. Cesana, et al., Curr. Microbiol., 24, 349 – 353 (1992).CrossRefGoogle Scholar
- 7.E. H. Abbas and T. Farghaly, Monatsh. Chem., 141, 661 – 667 (2010).CrossRefGoogle Scholar
- 8.M. Shafiq, M. Zia-Ur-Rehman, I. U. Khan, et al., Chil. Chem. Soc., 56, 527 – 531 (2011).CrossRefGoogle Scholar
- 9.M. Ahmad, S. U. F. Rizvi, H. L. Siddiqui, et al., Med. Chem. Res., 21, 2340 – 2348 (2012).CrossRefGoogle Scholar
- 10.P. Sharma and M. Kumar, Res. Chem. Intermed., 1 – 8 (2014).Google Scholar
- 11.P. Sharma, M. Kumar and S. Vats, Med. Chem. Res., 21, 2072 – 2078 (2012).CrossRefGoogle Scholar
- 12.M. Bukhari, H. L. Siddiqui, M. Ahmad, et al., Med. Chem. Res., 21, 2885 – 2895 (2012).CrossRefGoogle Scholar
- 13.M. Ahmad, H. L. Siddiqui, M. Zia-Ur-Rehman, and M. Parvez, Eur. J. Med. Chem., 45, 698 – 704 (2010).CrossRefPubMedGoogle Scholar
- 14.M. Ahmad, H. L. Siddiqui, J. M. Gardiner, et al., Med. Chem. Res., 22, 794 – 805 (2013).CrossRefGoogle Scholar
- 15.S. Aslam, M. Ahmad, M. Zia-Ur-Rehman, et al., Arch. Pharm. Res., 37, 1380 – 1393 (2014).CrossRefPubMedGoogle Scholar
- 16.Z. Otwinowski and W. Minor, in: Methods in Enzymology, Vol. 276: Macromolecular Crystallography. Part A, Ed. by C. W. Carter, Jr. and R. M. Sweet, Academic Press, New York (1997), pp. 307 – 326.Google Scholar
- 17.R. Hooft, COLLECT: User’s Manual, Nonius B. V., Delft, Netherlands (1998).Google Scholar
- 18.A. Altomare, M. Cascarano, C. Giacovazzo and A. Guagliardi, J. Appl. Cryst., 26, 343 – 350 (1993).CrossRefGoogle Scholar
- 19.P. T. Beurskens, G. Admiraal, G. Beurskens, et al., The DIRDIF-94 Program System:Technical Report of the Crystallography Laboratory, University of Nijmegen, Netherlands (1994).Google Scholar
- 20.G. M. Sheldrick, SHELXL97: A Program for Refinement of Crystal Structures, University of Gottingen, Germany (1997).Google Scholar
- 21.C. K. Johnson, ORTEPII: Report ORNL-5138, Oak Ridge National Laboratory, Tennessee, USA (1976).Google Scholar